How do I subscribe to ongoing alerts?

Subscribe to /feed/company/national-center-for-complementary-and-integrative-health-nccih.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

National Center for Complementary and Integrative Health (NCCIH) — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

National Center for Complementary and Integrative Health (NCCIH) pipeline: 13 marketed, 0 filed, 4 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

13 marketed 0 filed 4 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Black cohosh	Black cohosh	marketed	Herbal/botanical extract		Women's Health
Borage oil	Borage oil	marketed	Non-Standardized Plant Allergenic Extract [EPC]
Red clover	Red clover	marketed
Botanicals	Botanicals	marketed			Other
mistletoe	mistletoe	marketed			Other
chamomile tea	chamomile tea	marketed	Herbal anxiolytic/sedative	GABA receptors, benzodiazepine receptors	Neurology, Sleep Medicine, Gastroenterology
Isoflavones	Isoflavones	marketed			Other
Tylenol with codeine	Tylenol with codeine	marketed	Opioid analgesic combination	Mu opioid receptor (codeine); cyclooxygenase enzymes (acetaminophen)	Pain Management
MAK	MAK	marketed			Complementary and Integrative Health
Chondroitin	Chondroitin	marketed			Ophthalmology
Trifolium pratense	Trifolium pratense	marketed	Phytoestrogen / herbal supplement	Estrogen receptors (ERα, ERβ)	Women's Health / Menopause
Echinacea	Echinacea	marketed			Other

Therapeutic area mix

Other · 6
Cardiovascular · 2
Complementary and Integrative Health · 1
Dermatology · 1
Neurology, Sleep Medicine, Gastroenterology · 1
Ophthalmology · 1
Pain Management · 1
Women's Health · 1
Women's Health / Menopause · 1
Cardiovascular / Immunology / Infectious disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 2 shared drug classes
Ain Shams University · 1 shared drug class
Birjand University of Medical Sciences · 1 shared drug class
Albert Einstein College of Medicine · 1 shared drug class
Barrie Urology Associates · 1 shared drug class
BioNTech · 1 shared drug class
Albany Medical College · 1 shared drug class
Abbott · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for National Center for Complementary and Integrative Health (NCCIH):

Cite this brief

Drug Landscape (2026). National Center for Complementary and Integrative Health (NCCIH) — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/national-center-for-complementary-and-integrative-health-nccih. Accessed 2026-05-17.